Cargando…
Fc glycans of therapeutic antibodies as critical quality attributes
Critical quality attributes (CQA) are physical, chemical, biological or microbiological properties or characteristics that must be within an appropriate limit, range or distribution to ensure the desired product quality, safety and efficacy. For monoclonal antibody therapeutics that rely on fraction...
Autores principales: | Reusch, Dietmar, Tejada, Max L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634315/ https://www.ncbi.nlm.nih.gov/pubmed/26263923 http://dx.doi.org/10.1093/glycob/cwv065 |
Ejemplares similares
-
Structural basis for improved efficacy of therapeutic antibodies on defucosylation of their Fc glycans
por: Mizushima, Tsunehiro, et al.
Publicado: (2011) -
Assessing the Heterogeneity of the Fc-Glycan of a Therapeutic Antibody Using an engineered FcγReceptor IIIa-Immobilized Column
por: Kiyoshi, Masato, et al.
Publicado: (2018) -
EndoS and EndoS2 hydrolyze Fc-glycans on therapeutic antibodies with different glycoform selectivity and can be used for rapid quantification of high-mannose glycans
por: Sjögren, Jonathan, et al.
Publicado: (2015) -
Assessment of chemical modifications of sites in the CDRs of recombinant antibodies: Susceptibility vs. functionality of critical quality attributes
por: Haberger, Markus, et al.
Publicado: (2014) -
Chromatographic
Analysis of the N-Glycan Profile on Therapeutic
Antibodies Using FcγRIIIa
Affinity Column Chromatography
por: Hiranyakorn, Methanee, et al.
Publicado: (2023)